{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T08:00:31Z","timestamp":1780560031278,"version":"3.54.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,1,21]],"date-time":"2015-01-21T00:00:00Z","timestamp":1421798400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1245\/s10434-014-4349-3","type":"journal-article","created":{"date-parts":[[2015,1,20]],"date-time":"2015-01-20T19:32:08Z","timestamp":1421782328000},"page":"2978-2987","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Tumor Mitotic Rate Added to the Equation: Melanoma Prognostic Factors Changed?"],"prefix":"10.1245","volume":"22","author":[{"given":"M. J.","family":"Speijers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Bastiaannet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Sloot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. J. H.","family":"Suurmeijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. J.","family":"Hoekstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,21]]},"reference":[{"key":"4349_CR1","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","volume":"27","author":"CM Balch","year":"2009","unstructured":"Balch CM, Greshenwald JE, Soong SJ, et al. Final version of the 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27:6199\u2013206.","journal-title":"J Clin Oncol."},{"key":"4349_CR2","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1200\/JCO.2010.31.5812","volume":"29","author":"JF Thompson","year":"2011","unstructured":"Thompson JF, Soong SJ, Balch CM, et al. Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database. J Clin Oncol.\u00a02011;29:2199\u2013205.","journal-title":"J Clin Oncol."},{"key":"4349_CR3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1245\/ASO.2004.03.044","volume":"11","author":"VK Sondak","year":"2004","unstructured":"Sondak VK, Taylor JMG, Sabel MS, et al. Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model. Ann Surg Oncol. 2004;11:247\u201358.","journal-title":"Ann Surg Oncol."},{"key":"4349_CR4","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/cncr.22382","volume":"109","author":"SC Paek","year":"2006","unstructured":"Paek SC, Griffith KA, Johnson TM, et al. The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma. Cancer. 2006;109:100\u20138.","journal-title":"Cancer."},{"key":"4349_CR5","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.amjsurg.2010.07.037","volume":"200","author":"BA Roach","year":"2010","unstructured":"Roach BA, Burton AL, Mays MP, et al. Does mitotic rate predict sentinel lymph node metastasis or survival in patients with intermediate and thick melanoma? Am J Surg. 2010;200:759\u201364.","journal-title":"Am J Surg."},{"key":"4349_CR6","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.ejso.2011.05.003","volume":"37","author":"M Vries De","year":"2011","unstructured":"De Vries M, Speijers MJ, Bastiaannet E, et al. Long-term follow-up reveals that ulceration and sentinel lymph node status are the strongest predictors for survival in patients with primary cutaneous melanoma. Eur J Surg Oncol. 2011;37:681\u20137.","journal-title":"Eur J Surg Oncol."},{"key":"4349_CR7","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1053\/ejso.2002.1297","volume":"28","author":"MH Doting","year":"2002","unstructured":"Doting MH, Hoekstra HJ, Plukker JT, et al. Is sentinel node biopsy beneficial in melanoma patients? A report on 200 patients with cutaneous melanoma. Eur J Surg Oncol. 2002;28:673\u20138.","journal-title":"Eur J Surg Oncol."},{"key":"4349_CR8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3109\/00313028609090822","volume":"18","author":"VJ McGovern","year":"1986","unstructured":"McGovern VJ, Cochran AJ, Van der Esch EP et al. The classification of malignant melanoma, its histological reporting, and registration: a revision of the 1972 Sydney classification. Pathology. 1986;18:12\u201321.","journal-title":"Pathology."},{"key":"4349_CR9","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1245\/ASO.2004.07.014","volume":"11","author":"AB Francken","year":"2004","unstructured":"Francken AB, Shaw HM, Thompson JF, et al. The prognostic importance of tumor mitotic rate confirmed in 1,317 patients with primary cutaneous melanoma and long follow-up. Ann Surg Oncol. 2004;11:426\u201333.","journal-title":"Ann Surg Oncol."},{"key":"4349_CR10","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/cncr.11196","volume":"97","author":"MF Azzola","year":"2003","unstructured":"Azzola MF, Shaw HM, Thompson JF, et al. Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3,661 patients from a single center. Cancer. 2003;97:1488\u201398.","journal-title":"Cancer."},{"key":"4349_CR11","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ejca.2005.10.023","volume":"42","author":"ACJ Akkooi Van","year":"2006","unstructured":"Van Akkooi ACJ, de Wilt JHw, Verhoef C, et al. High positive sentinel identification rate by EORTC Melanoma Group Protocol: prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma. Eur J Cancer. 2006;42:372\u201380.","journal-title":"Eur J Cancer."},{"key":"4349_CR12","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1200\/JCO.1999.17.3.976","volume":"17","author":"JE Gershenwald","year":"1999","unstructured":"Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol. 1999;17:976\u201383.","journal-title":"J Clin Oncol."},{"key":"4349_CR13","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1245\/s10434-011-1826-9","volume":"18","author":"RL White","year":"2011","unstructured":"White RL, Ayers GD, Stell VH, et al. Factors predictive of the status of sentinel lymph nodes in melanoma patients from a large multicenter database. Ann Surg Oncol. 2011;18: 3593\u2013600.","journal-title":"Ann Surg Oncol."},{"key":"4349_CR14","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1002\/cncr.22295","volume":"107","author":"LL Kruper","year":"2006","unstructured":"Kruper LL, Spitz FR, Czerniekcki BJ, et al. Predicting sentinel node status in AJCC stage I\/II primary cutaneous melanoma. Cancer. 2006;107:2436\u201345.","journal-title":"Cancer."},{"key":"4349_CR15","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1245\/ASO.2006.03.019","volume":"13","author":"S Mocellin","year":"2006","unstructured":"Mocellin S, Ambrosi A, Montesco MC, et al. Support vector machine learning model for the prediction of sentinel node status in patients with cutaneous melanoma. Ann Surg Oncol. 2006;13:1113\u201322.","journal-title":"Ann Surg Oncol."},{"key":"4349_CR16","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/sj.bjc.6605849","volume":"103","author":"A Mitra","year":"2010","unstructured":"Mitra A, Conway C, Walker C, et al. Melanoma sentinel node biopsy and prediction models for relapse and overall survival. Br J Cancer. 2010;103:1229\u201336.","journal-title":"Br J Cancer."},{"key":"4349_CR17","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.bjps.2012.04.019","volume":"65","author":"NG Fairbairn","year":"2012","unstructured":"Fairbairn NG, Orfaniotis G, Butterworth M. Sentinel lymph node biopsy in thick malignant melanoma: a 10-year single-unit experience. J Plast Reconstr Aesthet Surg. 2012;65:1396\u2013402.","journal-title":"J Plast Reconstr Aesthet Surg."},{"key":"4349_CR18","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1245\/ASO.2006.05.011","volume":"13","author":"GC Karakousis","year":"2006","unstructured":"Karakousis GC, Gimotty PA, Botbyl JD, et al. Predictors of regional nodal disease in patients with thin melanomas. Ann Surg Oncol. 2006;13:533\u201341.","journal-title":"Ann Surg Oncol."},{"key":"4349_CR19","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1309\/LB7RTC61B7LC6HJ6","volume":"127","author":"MG Attis","year":"2007","unstructured":"Attis MG, Vollmer RT. Mitotic rate in melanoma: a reexamination. Am J Clin Pathol. 2007;127:380\u20134.","journal-title":"Am J Clin Pathol."},{"key":"4349_CR20","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1002\/(SICI)1097-0142(19990601)85:11<2391::AID-CNCR14>3.0.CO;2-I","volume":"85","author":"H Ostmeier","year":"1999","unstructured":"Ostmeier H,\u00a0Fuchs B,\u00a0Otto F, et al. Can immunohistochemical markers and mitotic rate improve prognostic precision in patients with primary melanoma? Cancer. 1999;85:2391\u20139.","journal-title":"Cancer."},{"key":"4349_CR21","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00008390-200112000-00008","volume":"11","author":"MH Schmid-Wendtner","year":"2001","unstructured":"Schmid-Wendtner MH, Baumert J, Schmidt M, et al. Prognostic index for cutaneous melanoma: an analysis after follow-up of 2,715 patients. Melanoma Res. 2001;11:619\u201326.","journal-title":"Melanoma Res."},{"key":"4349_CR22","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1245\/s10434-013-3100-9","volume":"20","author":"CM Balch","year":"2013","unstructured":"Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Coit DG, Atkins MB, et al. Age as a prognostic factor in patients with localized melanoma and regional metastases. Ann Surg Oncol. 2013;20:3961\u20138.","journal-title":"Ann Surg Oncol."},{"key":"4349_CR23","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.amjsurg.2010.07.025","volume":"200","author":"CCH Stucky","year":"2010","unstructured":"Stucky CCH, Gray RJ, Dueck AC, et al. Risk factors associated with local in-transit recurrence of cutaneous melanoma. Am J Surg. 2010;200:770\u20135.","journal-title":"Am J Surg."},{"key":"4349_CR24","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1097\/00000478-200312000-00011","volume":"27","author":"RA Scolyer","year":"2003","unstructured":"Scolyer RA, Shaw HM, Thompson JF, et al. Interobserver reproducibility of histopathologic prognostic variables in primary melanoma. Am J Surg Pathol. 2003;27:1571\u20136.","journal-title":"Am J Surg Pathol."},{"key":"4349_CR25","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1200\/JCO.2009.27.1627","volume":"28","author":"CM Balch","year":"2010","unstructured":"Balch CM, Gerschenwald JE, Soong SJ, Thompson JF, Ding S, et al. Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: compariscon of nodal micrometastases versus macrometastases. J Clin Oncol. 2010;28:2452\u20139.","journal-title":"J Clin Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-014-4349-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-014-4349-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-014-4349-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T22:36:01Z","timestamp":1566254161000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-014-4349-3"}},"subtitle":["A Single-Institution Database Study on the Prognostic Value of Tumor Mitotic Rate for Sentinel Lymph Node Status and Survival of Cutaneous Melanoma Patients"],"short-title":[],"issued":{"date-parts":[[2015,1,21]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["4349"],"URL":"https:\/\/doi.org\/10.1245\/s10434-014-4349-3","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,21]]}}}